177 related articles for article (PubMed ID: 37793911)
1. Low- and High-Density Lipoprotein Cholesterol and Dementia Risk Over 17 Years of Follow-up Among Members of a Large Health Care Plan.
Ferguson EL; Zimmerman SC; Jiang C; Choi M; Swinnerton K; Choudhary V; Meyers TJ; Hoffmann TJ; Gilsanz P; Oni-Orisan A; Whitmer RA; Risch N; Krauss RM; Schaefer CA; Glymour MM
Neurology; 2023 Nov; 101(21):e2172-e2184. PubMed ID: 37793911
[TBL] [Abstract][Full Text] [Related]
2. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
3. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
Kazerooni R; Watanabe JH; Bounthavong M
Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
[TBL] [Abstract][Full Text] [Related]
4. Is LDL cholesterol associated with long-term mortality among primary prevention adults? A retrospective cohort study from a large healthcare system.
Kip KE; Diamond D; Mulukutla S; Marroquin OC
BMJ Open; 2024 Mar; 14(3):e077949. PubMed ID: 38548371
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
6. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
7. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
8. Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease-Related Dementias.
Moser ED; Manemann SM; Larson NB; St Sauver JL; Takahashi PY; Mielke MM; Rocca WA; Olson JE; Roger VL; Remaley AT; Decker PA; Killian JM; Bielinski SJ
Neurology; 2023 Sep; 101(11):e1127-e1136. PubMed ID: 37407257
[TBL] [Abstract][Full Text] [Related]
9. Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus.
Rana JS; Liu JY; Moffet HH; Boklage SH; Khan I; Karter AJ
Am J Cardiol; 2018 Sep; 122(5):762-767. PubMed ID: 30057224
[TBL] [Abstract][Full Text] [Related]
10. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.
Boekholdt SM; Arsenault BJ; Hovingh GK; Mora S; Pedersen TR; Larosa JC; Welch KM; Amarenco P; Demicco DA; Tonkin AM; Sullivan DR; Kirby A; Colhoun HM; Hitman GA; Betteridge DJ; Durrington PN; Clearfield MB; Downs JR; Gotto AM; Ridker PM; Kastelein JJ
Circulation; 2013 Oct; 128(14):1504-12. PubMed ID: 23965489
[TBL] [Abstract][Full Text] [Related]
11. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
12. Circulating metabolites and risk of incident dementia: A prospective cohort study.
Huang SY; Zhang YR; Yang L; Li YZ; Wu BS; Chen SD; Feng JF; Dong Q; Cheng W; Yu JT
J Neurochem; 2023 Dec; 167(5):668-679. PubMed ID: 37908051
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
14. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma EM; Leeper NJ; Heidenreich PA
J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
[TBL] [Abstract][Full Text] [Related]
18. Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study.
Marcum ZA; Walker R; Bobb JF; Sin MK; Gray SL; Bowen JD; McCormick W; McCurry SM; Crane PK; Larson EB
J Am Geriatr Soc; 2018 Dec; 66(12):2344-2352. PubMed ID: 30289959
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort.
Miles J; Scotti A; Castagna F; Kuno T; Leone PP; Coisne A; Ludwig S; Lavie CJ; Joshi PH; Latib A; Garcia MJ; Rodriguez CJ; Shapiro MD; Virani SS; Slipczuk L
Circulation; 2024 Feb; 149(6):417-426. PubMed ID: 37970713
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
Ballantyne CM; Raichlen JS; Cain VA
J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]